Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Vanguard Extended Market ETF (NY:VXF)

185.48 -1.43 (-0.77%)
Streaming Delayed Price Updated: 10:45 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9 Next >
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic
The company said that the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20. 
Via Stocktwits
Topics Government
Exposures Political
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end. 
Via Stocktwits
Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive
In his role at Celgene Corp, Hand played a strategic role in transactions including the $74 billion acquisition of Celgene by Bristol Myers Squibb and its subsequent integration. 
Via Stocktwits
Chegg To Layoff 22% Of Its Workforce, CEO Says Trends Impacting Business Will Worsen Before They Get Better
The measures are expected to generate $45 million to $55 million of savings in 2025, with full-year savings of $100 million to $110 million in 2026. 
Via Stocktwits
Topics Workforce
Exposures Layoff
Papa John's Stock Climbs After Q1 Revenue Beat Amid Challenging Times For Restaurants: Retail Mood Neutral
Shares jumped 16% on Thursday following the results, leading to a third consecutive week of gains for the stock. 
Via Stocktwits
Coinbase Q1 Earnings, Deribit Acquisition Draws Mixed Response From Wall Street
JPMorgan lowered its price target on Coinbase to $215 from $276 and kept a ‘Neutral’ rating on the shares, as per TheFly. 
Via Stocktwits
Topics Derivatives
Exposures Derivatives
Corvus Gets Price Target Hike From Oppenheimer On Positive Drug Trial Results: Retail’s Pleased
Corvus announced new interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis. 
Via Stocktwits
Crocs Stock Soars Following Upbeat Q1 Results As Investors Brush Aside Withdrawal Of Full-Year Guidance
CEO Andrew Rees said the new global trade environment and business and consumer uncertainty have made it challenging to predict how consumers may respond. 
Via Stocktwits
Topics Derivatives
Exposures Derivatives
Coinbase Stock Rallies After Announcing $2.9B Deribit Acquisition Aimed At Boosting Derivatives Business
The company expects the acquisition to add diversity and durability to its trading revenues, given that options trading revenues are typically less cyclical than spot trading. 
Via Stocktwits
Topics Derivatives Government
Exposures Derivatives Political
WeightWatchers Seeks Chapter 11 Bankruptcy Protection As GLP-1 Obesity Drugs Reshape Industry
The company said the reorganization plan would eliminate $1.15 billion in debt from its balance sheet 
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal
Celsius Holdings Stock Drops After Q1 Earnings, Revenue Miss – CEO Remains Upbeat On Q2
Celsius’s North American revenue declined 10% year over year to $306.5 million, but International revenue jumped 41% year over year to $22.8 million. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Skechers Analysts See Easy Path To $9B Buyout From 3G Capital
Investment firm Stifel said the deal "represents a pathway to value realization for similarly tariff-impacted businesses with solid franchises and attractive valuation." 
Via Stocktwits
Topics World Trade
Exposures Tariff
Hyperscale Data Stock On Track For Biggest One-Day Gain In 30-Year History After Preliminary Q1 Revenue Tops $25M
CEO William B. Horne said the year began with growth across several core business segments. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Skechers Stock Soars After 3G Capital Agrees To Acquire The Company For $9.4B
Skechers shareholders can elect to receive $63 per share in cash or $57 per share in cash and one unlisted, non-transferable equity unit (LLC unit) in a newly formed, privately held firm that will be... 
Via Stocktwits
Topics World Trade
Exposures Tariff
Hims & Hers Appoints Amazon Veteran Nader Kabbani COO To Support Expansion
A nearly 20-year Amazon veteran, Nader Kabbani said he was drawn to Hims & Hers by its potential to expand access to fast, reliable, and high-quality care. 
Via Stocktwits
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence COVID-19 Interest Rates
Block’s Stock Sinks To 18-Month Low After Multiple Downgrades On Wall Street Over Slowing Cash App Growth
Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’ and slashed its price target to $50 from $95. 
Via Stocktwits
Etsy Stock Rises On Upbeat Q1 Revenue, Company Says It’s Staying Nimble In The Wake Of Tariff-Led Uncertainties
However, the e-commerce player reported a net loss of $52.1 million during the quarter compared to a profit of $63 million in the same quarter a year ago, reflecting an impairment charge of $101.7... 
Via Stocktwits
Topics Earnings World Trade
Exposures Financial Tariff
WeightWatchers Stock Rockets After Partnership For Eli Lilly's Zepbound Drug: Retail Investors Very Optimistic
Eligible self-pay patients without insurance can now access prescriptions for Zepbound in single-dose vial form through the WeightWatchers app. 
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal
Abeona Therapeutics’ Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin Disease
ZEVASKYN is expected to be available beginning in the third quarter of 2025 through ZEVASKYN Qualified Treatment Centers, located across the U.S. with experience in cell and gene therapy. 
Via Stocktwits
Exposures Product Safety
WeightWatchers Bankruptcy Buzz Could Be A Strategy To 'Get A Better Deal With The Bonds,' Says Activist Investor
Galloway Capital, which owns a 2.87% stake, says WeightWatchers should avoid bankruptcy. 
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal
American Airlines Withdraws Full-Year Guidance Amid Economic Uncertainty, Reports Narrower Q1 Losses
CEO Robert Isom highlighted that the airline’s actions over the past several years to refresh its fleet, manage costs, and strengthen its balance sheet position it well for the uncertainty the industry... 
Via Stocktwits
Topics Earnings
Exposures Financial
TNF Pharmaceuticals To Use AI To Recruit Patients For Drug Development: Retail Stays Bearish
The company stated that the TNF-Renova partnership is analyzing data from 30,000 patients to identify high-risk patients. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays Bearish
During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries. 
Via Stocktwits
Exposures Product Safety
Faraday Future Expects Short Term Impact From Trump Tariffs But Retail Is Positive
The company said that its second brand, Faraday X, plans to source components internationally in the early phase of production. 
Via Stocktwits
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
Comerica Q1 2025 Earnings Top Wall Street Estimates, Revenue Fails To Meet Expectations As Loan Demand Remains Muted
CEO Curtis C. Farmer said that stronger-than-expected non-interest-bearing balances and proactive deposit pricing strategies offset the impact of muted loan demand. 
Via Stocktwits
Topics Government Stocks
Exposures Political US Equities
uniQure Stock Jumps On FDA’s Breakthrough Therapy Designation For Investigational Gene Therapy: Retail’s Optimistic
The new designation is in addition to the existing Regenerative Medicine Advanced Therapy, Orphan Drug, and Fast Track designations granted to AMT-130. 
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal Product Safety
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed
Every eight shares of Biomerica’s pre-split common stock issued and outstanding will be automatically reclassified as and converted into one new share of Biomerica’s common stock on Monday. 
Via Stocktwits
Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled
The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed. 
Via Stocktwits
Topics Government
Exposures Political
Cara Therapeutics Stock Jumps 10% After Announcing 1-for-3 Reverse Stock Split: Retail Sentiment Soars
On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the... 
Via Stocktwits
Topics Economy
Exposures COVID-19 Interest Rates
Bath & Body Works Stock Upgraded By Piper Sandler On Strong Brand Interest, Attractive Share Price: Retail Investors Very Interested
The brand was a popular choice for fragrances among teenagers in the U.S., according to a Piper Sandler survey. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.